AR116956A1 - GALANINE 2 RECEPTOR AGONISTS - Google Patents
GALANINE 2 RECEPTOR AGONISTSInfo
- Publication number
- AR116956A1 AR116956A1 ARP190103195A ARP190103195A AR116956A1 AR 116956 A1 AR116956 A1 AR 116956A1 AR P190103195 A ARP190103195 A AR P190103195A AR P190103195 A ARP190103195 A AR P190103195A AR 116956 A1 AR116956 A1 AR 116956A1
- Authority
- AR
- Argentina
- Prior art keywords
- galanine
- receptor agonists
- proteins
- galanin
- gal2
- Prior art date
Links
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical group C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a una proteína quimérica que comprende: (i) un fragmento de galanina que consta de los residuos 2-13 de galanina (Gal2-13) o una variante de ella, y (ii) una región Fc así como también una composición farmacéutica que comprende estas proteínas. Estas proteínas son adecuadas para usar en el tratamiento del dolor.This refers to a chimeric protein comprising: (i) a galanin fragment consisting of galanin residues 2-13 (Gal2-13) or a variant thereof, and (ii) an Fc region as well as a pharmaceutical composition comprising these proteins. These proteins are suitable for use in treating pain.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1817943.2A GB201817943D0 (en) | 2018-11-02 | 2018-11-02 | Galanin-2 receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR116956A1 true AR116956A1 (en) | 2021-06-30 |
Family
ID=64655466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190103195A AR116956A1 (en) | 2018-11-02 | 2019-11-01 | GALANINE 2 RECEPTOR AGONISTS |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR116956A1 (en) |
| GB (1) | GB201817943D0 (en) |
-
2018
- 2018-11-02 GB GBGB1817943.2A patent/GB201817943D0/en not_active Ceased
-
2019
- 2019-11-01 AR ARP190103195A patent/AR116956A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201817943D0 (en) | 2018-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019002371A2 (en) | Adenovirus armed with bispecific t lymphocyte scavenger (bite) | |
| ECSP19046893A (en) | NEW COMPOUNDS AS TRIGONAL PEPTIDIC AGONISTS OF GLP1 / GLUCAGON / GIP RECEPTORS | |
| DOP2020000050A (en) | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES OF THEM | |
| CO2021008089A2 (en) | Glp-1r agonists and their uses | |
| CL2021003477A1 (en) | 2,3-dihydroquinazoline compounds as nav1 .8 inhibitors | |
| CO2023003322A2 (en) | Compounds as glp-1r agonists | |
| ECSP20025070A (en) | TRISPECIFIC PROTEINS AND METHODS OF USE | |
| CO2017000399A2 (en) | Mitogen Activated Protein Kinase (MNK) Interaction Kinase Inhibitors and Related Methods | |
| PE20161170A1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING AZD9291 | |
| CO2021010150A2 (en) | Irreversible inhibitors of the menin-mll interaction | |
| AR067555A1 (en) | DERIVATIVE OF INSULINOTROPIC PEPTIDE IN WHICH THE N-TERMINAL AMINO ACID IS MODIFIED | |
| CO2017006308A2 (en) | Glucagon derivatives | |
| AR099975A1 (en) | DERIVATIVES OF EXENDINA-4 AS DUAL PEPTIDE AGONISTS OF THE GLP-1 / GLUCAGÓN RECEPTOR | |
| CL2011003160A1 (en) | Heterocyclic derived compounds, cb2 modulators; pharmaceutical composition comprising them; and use in the treatment of rheumatic, autoimmune, inflammatory diseases, pain, among others. | |
| CL2017002913A1 (en) | Treatment of postbariatric hypoglycemia with exendin (9-39) | |
| CL2020002574A1 (en) | Novel analogs of glp-1 | |
| CU20170048A7 (en) | CRY1DA1 AMINO ACID SEQUENCE VARIATIONS PROTEINS FOR LEPIDOPTERS | |
| AR122018A1 (en) | NKG2D, CD16 AND CLEC12A BINDING PROTEINS | |
| AR104173A1 (en) | PROTOXIN II VARIANTS AND METHODS OF USE | |
| CO2018002534A2 (en) | Sedation methods and parenteral formulation for use during critical care treatment | |
| CO2021015793A2 (en) | Methods of treating or preventing asthma by administering an il-33 antagonist | |
| CO2020005919A2 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| PE20231376A1 (en) | ANTIBODIES AGAINST SARS-COV-2 AND METHODS AND SELECTION AND USE THEREOF | |
| CO2019006424A2 (en) | Anti-gitr antigen binding proteins and methods of use thereof | |
| CL2021000924A1 (en) | Use of reboxetine for the treatment of narcolepsy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |